Vered Caplan's most recent trade in Orgenesis Inc was a trade of 85,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 23, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Orgenesis Inc | Vered Caplan | Director, CEO & CHAIRMAN OF THE BOARD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2024 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
| Orgenesis Inc | Vered Caplan | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 85,000 | 85,000 | - | - | Stock Option | |
| Orgenesis Inc | Vered Caplan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2022 | 278,191 | 0 | - | - | Stock Option (Right to Buy) | |
| Orgenesis Inc | Vered Caplan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.01 per share. | 28 Jan 2022 | 278,191 | 278,191 (1%) | 1% | 0.0 | 3,338 | Common Stock |